In the former assay, we observed that patients with SLE showed a significant diminution in the suppressor activity of CD4+CD25+Foxp3+ cells compared to healthy controls (p < 0.05, Figure 4(b)). This evidence concerns the gene FOXP3 and systemic lupus erythematosus.